New & Noteworthy

January 2023

Lacosamide Injection, USP

Fresenius Kabi USA

Fresenius Kabi adds lacosamide injection to its product portfolio. The lacosamide injection, USP is supplied in a 200 mg per 20 mL single-dose vial presentation for intravenous (IV) use.

Request More Information

Current Issue